Skip to main content
. Author manuscript; available in PMC: 2015 Feb 25.
Published in final edited form as: Adv Healthc Mater. 2014 Aug 22;4(3):367–376. doi: 10.1002/adhm.201400336

Figure 6.

Figure 6

Function of the liver and spleen upon PAM administration. A) Liver and B) spleen caspase activity of early- and late-stage ApoE knock-out mice treated with MCP-1 or scrambled PAMs show no statistical significance with early-stage mice treated with PBS. Liver function was assessed via C) alanine aminotransferase (ALT) and D) aspartate aminotransferase activity (AST). Data points are mean ± SD and no statistical significance was found for all assays when compared to early-stage mice treated with PBS.